Thus, distinct activation of status of TG2 (compact versus extended) in a cell may be a reflection of the fact that TG2 functions as a double-edged sword in cancer cells, conferring advantage or disadvantage to the tumor. This evidence concerns the gene TGM2 and neoplasm.